Deutsche Bank’s Black Diamond Therapeutics BDTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$76.1K Sell
40,261
-5,777
-13% -$11.3K ﹤0.01% 3423
2026
Q2
$85.2K Buy
+46,038
New +$113K ﹤0.01% 3506
2025
Q2
– Sell
-22,388
Closed -$34.7K – 3617
2025
Q1
$34.7K Hold
22,388
– – ﹤0.01% 3432
2024
Q4
$47.9K Hold
22,388
– – ﹤0.01% 3421
2024
Q3
$97.4K Hold
22,388
– – ﹤0.01% 3227
2024
Q2
$104K Buy
+22,388
New +$120K ﹤0.01% 3093
2022
Q4
– Sell
-321,602
Closed -$544K – 4010
2022
Q3
$544K Buy
+321,602
New +$992K ﹤0.01% 2322
2022
Q2
– Sell
-12,363
Closed -$34K – 4134
2022
Q1
$34K Sell
12,363
-1,462
-11% -$5.34K ﹤0.01% 3943
2021
Q4
$74K Sell
13,825
-11,138
-45% -$77.8K ﹤0.01% 3826
2021
Q3
$211K Sell
24,963
-91,882
-79% -$907K ﹤0.01% 3542
2021
Q2
$1.42M Buy
116,845
+104,380
+837% +$2.06M ﹤0.01% 2538
2021
Q1
$302K Sell
12,465
-1,095
-8% -$29.5K ﹤0.01% 3407
2020
Q4
$435K Buy
13,560
+3,637
+37% +$119K ﹤0.01% 3000
2020
Q3
$300K Sell
9,923
-5,747
-37% -$175K ﹤0.01% 2964
2020
Q2
$661K Buy
15,670
+2,045
+15% +$75.3K ﹤0.01% 2481
2020
Q1
$340K Buy
+13,625
New +$415K ﹤0.01% 2679

Other funds holding BDTX

Deutsche Bank's BDTX Position: Q3 2026 in Review

Deutsche Bank reduced its Black Diamond Therapeutics (BDTX) stake by 13% in Q3 2026, selling an estimated $11.3K and leaving 40,261 shares worth $76.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3423.

Deutsche Bank first reported a position in BDTX in Q1 2020 and has held it in 16 quarters since. The position peaked at $1.42M in Q2 2021. 105 funds tracked by Wall St. Rank hold BDTX as of Q3 2026.

  • Deutsche Bank held 40,261 shares of Black Diamond Therapeutics worth $76.1K as of Q3 2026.
  • Deutsche Bank sold 5,777 Black Diamond Therapeutics shares in Q3 2026, an estimated $11.3K.
  • Black Diamond Therapeutics made up ﹤0.01% of Deutsche Bank's portfolio in Q3 2026, its #3423 holding.
  • Deutsche Bank first reported a position in Black Diamond Therapeutics in Q1 2020 and has held it in 16 quarters since.
  • Deutsche Bank's Black Diamond Therapeutics position peaked at $1.42M in Q2 2021.
  • 105 funds tracked by Wall St. Rank held Black Diamond Therapeutics as of Q3 2026.

Based on Deutsche Bank's 13F filing for Q3 2026, filed 6 Nov 2026.